Aug 29, 2023 | Infection Control, News
Vaxess Technologies, Inc., a life sciences company developing a shelf-stable vaccine patch with potential for self-application, announced that it is collaborating with AstraZeneca for the evaluation of an RNA-based pandemic influenza prototype vaccine in patch format.... 
Aug 29, 2023 | Covid-19, News
The US Centers for Disease Control and Prevention (CDC) issued its initial risk assessment of the BA.2.86 SARS-CoV-2 lineage, which says tests and treatments will likely be effective and that updated vaccines will still be able to reduce severe disease and... 
Aug 29, 2023 | News, Uncategorized
Researchers at the University of East Anglia have developed a new way of identifying patients at risk of an irregular heartbeat, known as atrial fibrillation. While not life threatening, the condition increases people’s risk of having a transient ischaemic attack... 
Aug 22, 2023 | Covid-19, News
In one of the largest studies of its kind, researchers provide answers to whether COVID-19 vaccinations reduce sickness and mortality following infection with SARS-CoV-2. The study published in The Lancet Microbe found among individuals recently infected with... 
Aug 22, 2023 | Covid-19, News
Colorized scanning electron micrograph of a cell infected with a variant strain of SARS-CoV-2 virus particles (green), isolated from a patient sample. CREDIT: NIAID/NIH Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of...
